Bio
Dr. Koo is a board-certified ophthalmologist with the Byers Eye Institute at Stanford Health Care and a clinical assistant professor in the Department of Ophthalmology.
Dr. Koo diagnoses and treats a wide range of eye conditions, such as blepharitis, macular degeneration, diabetic retinopathy, farsightedness, cataracts, and glaucoma. She performs a range of surgical procedures, including cataract surgery, chalazia excisions, and laser glaucoma surgery. Dr. Koo creates a comprehensive, personalized treatment plan for each of her patients.
In addition to her clinical responsibilities, Dr. Koo is involved in the education and oversight of medical students, interns, and Ophthalmology residents spanning all settings from the classroom to the clinic, operating room, and the hospital.
Dr. Koo researches best practices in ophthalmologic care. Her research has included case studies to evaluate treatments in adults and children.
Dr. Koo’s work has been published in peer-reviewed journals, including Retina and the Journal of Pediatric Ophthalmology and Strabismus. She has been invited to moderate and present at regional, national, and international meetings, including the World Ophthalmology Congress.
Clinical Focus
- Ophthalmology
Academic Appointments
-
Clinical Assistant Professor, Ophthalmology
Professional Education
-
Board Certification: American Board of Ophthalmology, Ophthalmology (2020)
-
Residency: Bascom Palmer Eye Institute (2019) FL
-
Internship: Beth Israel Deaconess Medical Center Internal Medicine Residency (2016) MA
-
Medical Education: Harvard Medical School (2015) MA
-
Bachelor of Science, University of Florida, Biochemistry, Business Admin (2009)
2024-25 Courses
- Clinical Topics in Ophthalmology
OPHT 201 (Aut) -
Prior Year Courses
2023-24 Courses
- Clinical Topics in Ophthalmology
OPHT 201 (Spr)
- Clinical Topics in Ophthalmology
All Publications
-
Endogenous Fusarium Endophthalmitis after Bone Marrow Transplant: A Case Report and Literature Review.
Vision (Basel, Switzerland)
2024; 8 (3)
Abstract
We aim to present a case of disseminated fusariosis that occurred in the setting of immunosuppression and presented with bilateral endogenous endophthalmitis, along with a literature review of Fusarium endophthalmitis, highlighting management strategies.A 70-year-old male with acute myeloid leukemia who had recently undergone a bone marrow transplant noted bilateral floaters and decreased vision. He was found to have bilateral Fusarium endophthalmitis, with subsequent evidence of fungemia and fusariosis in his skin and joints. Despite aggressive local and systemic treatment, he succumbed to the disease. Endophthalmitis was initially stabilized with pars plana vitrectomy and intravitreal amphotericin and voriconazole until the patient transitioned to comfort measures. A review of 31 cases demonstrates that outcomes are poor and that the disease must be treated aggressively, often both systemically and surgically.This case highlights the recalcitrance of Fusarium bacteremia and Fusarium endophthalmitis.
View details for DOI 10.3390/vision8030044
View details for PubMedID 39051230